In July 2025, Becton, Dickinson and Company (NYSE:BDX) agreed to combine its Biosciences & Diagnostic Solutions business with Waters Corporation (NYSE:WAT). On Monday, William Blair initiated coverage on Waters with an Outperform rating. Investment Thesis While the merger adds complexity to…
Featured
Anheuser-Busch Inbev (NYSE:BUD) shares climbed Tuesday as the company announced a major production and economic investment in Jacksonville, Florida. The firm said it will spend $30 million to upgrade brewing and packaging operations at its Jacksonville brewery and can plant,…
Meta Platforms Inc. (NASDAQ:META) is delaying its planned international rollout of the Ray-Ban Display smart glasses as demand in the U.S. has rapidly outpaced supply, forcing the company to rethink its global launch timeline. Meta had initially targeted early 2026…
Wall Street has kicked off 2026 on a strong footing, with large-cap indexes heading toward a third straight session of gains on Tuesday. By midday trading in New York, the Dow Jones Industrial Average rallied nearly 1%, extending record highs…
STAAR Surgical Company (NASDAQ:STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE:ALC) at the Special Meeting of Stockholders. STAAR intends to terminate its merger agreement with Alcon. No termination…
Health care ETFs could emerge as one of the stronger performers in 2026 as investors grow cautious about pricey AI stocks. • State Street Health Care Select Sector SPDR ETF shares are trending higher. Why is XLV stock advancing? Analysts,…
U.S. airlines are entering 2026 with tight capacity and resilient premium demand, creating a setup where carriers with pricing power and strong cash generation are poised to pull further ahead of weaker peers. Bank of America Securities analyst Andrew G.…
Apogee Therapeutics, Inc. (NASDAQ:APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients with mild-to-moderate asthma. The trial also evaluated fractional exhaled nitric oxide (FeNO)…
When a hedge fund adds aggressively into a falling stock, it's rarely about momentum — it's about conviction. That's what's drawing attention to Chewy Inc (NYSE:CHWY), after Viking Global Investors, led by Andreas Halvorsen, sharply increased its position. Track CHWY…
For Walt Disney Co (NYSE:DIS), the holiday season has historically been an important quarter. Here are the key analyst insights: Goldman Sachs analyst Michael Ng maintained a Buy rating and a $151 price target. BofA Securities analyst Jessica Reif…









